Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invitro InternationalIVRO +1.33% Current Ratio is 12.42 as of Mar. 2026, which is 6% below its 10-year median of 13.26. The stock has 1 warning sign investors should review. Among 213 Medical Diagnostics & Research companies, Invitro International ranks better than 96.71% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Invitro International's current ratio for the quarter that ended in Mar. 2026 was 12.42.
Invitro International has a current ratio of 12.42. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Invitro International's Current Ratio or its related term are showing as below:
IVRO'
s Current Ratio Range Over the Past 10 Years
Min: 12.21 Med: 13.26 Max: 16.68
Current: 12.42
During the past 9 years, Invitro International's highest Current Ratio was 16.68. The lowest was 12.21. And the median was 13.26.
IVRO's Current Ratio is ranked better than 96.71% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.1
vs IVRO: 12.42
Invitro International (OTCPK:IVRO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Invitro International Current Ratio Related Terms
Invitro International Current Ratio Historical Data
* Premium members only.
The historical data trend for Invitro International's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVRO vs IDTA, PRPH, NSTM: Current Ratio Comparison
For the Diagnostics & Research subindustry, Invitro International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invitro International Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Current Ratio distribution charts can be found below:
* The bar in red indicates where Invitro International's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invitro International (IVRO) has a Current Ratio of 12.42 as of Mar. 2026. This is near median its historical median of 13.26. Over the past decade, Invitro International's Current Ratio has ranged from 12.21 to 16.68. According to the industry distribution chart, Invitro International ranks #7 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 3.3%.
Is Invitro International's Current Ratio too high?
Invitro International's current Current Ratio of 12.42 is near median its 10-year median of 13.26. Over the past 10 years, this metric has ranged from a low of 12.21 to a high of 16.68. The Medical Diagnostics & Research industry median Current Ratio is 2.10. Invitro International's value of 12.42 is 491.4% above this industry median. Based on the distribution chart, Invitro International ranks #7 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Current Ratio compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #7 out of 213 companies for Current Ratio. This places Invitro International in the top 3% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.10. Invitro International's value of 12.42 is 491.4% above this benchmark. Historically, Invitro International's own Current Ratio has ranged from 12.21 to 16.68 over the past decade. While the company's 10-year median is 13.26 vs. the industry median of 2.10, Invitro International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.10, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invitro International's current Current Ratio of 12.42 is 491.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invitro International's current Current Ratio is 12.42, which is near median its own 10-year median of 13.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 35.8% above its estimated fair value. The current Current Ratio is 12.42, which is near median its 10-year median of 13.26 and 491.4% above the Medical Diagnostics & Research industry median of 2.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Invitro International (IVRO), the current Current Ratio is 12.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVRO has been successfully added to your 
